MIRA INFORM REPORT

Report Date :

24.12.2014

IDENTIFICATION DETAILS

Name :	BIZCOM JAPAN INC.
Registered Office :	K2 Bldg. 7F., 5-28-1, Higashi-gotanda, Shinagawa-ku, Tokyo 141-0022
Country :	Japan
Date of Incorporation :	24.12.1996
Com. Reg. No.:	0108-01-020911
Legal Form :	Private Company
Line of Business :	Trader of Biochemical products
No. of Employees :	05

RATING & COMMENTS

MIRA’s Rating :

B

RATING		STATUS	PROPOSED CREDIT LINE
26-40	B	Capability to overcome financial difficulties seems comparatively below average.	Small

Maximum Credit Limit :	US$ 25,000
Status :	Moderate
Payment Behaviour :	No Complaints
Litigation :	Clear

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

ECGC Country Risk Classification List – September 30, 2014

Country Name	Previous Rating (30.06.2014)	Current Rating (30.09.2014)
Japan	A1	A1

Risk Category	ECGC Classification
Insignificant	A1
Low	A2
Moderate	B1
High	B2
Very High	C1
Restricted	C2
Off-credit	D

JAPAN - ECONOMIC OVERVIEW

In the years following World War II, government-industry cooperation, a strong work ethic, mastery of high technology, and a comparatively small defense allocation (1% of GDP) helped Japan develop a technologically advanced economy. Two notable characteristics of the post-war economy were the close interlocking structures of manufacturers, suppliers, and distributors, known as keiretsu, and the guarantee of lifetime employment for a substantial portion of the urban labor force. Both features are now eroding under the dual pressures of global competition and domestic demographic change. Japan's industrial sector is heavily dependent on imported raw materials and fuels. A small agricultural sector is highly subsidized and protected, with crop yields among the highest in the world. While self-sufficient in rice production, Japan imports about 60% of its food on a caloric basis. For three decades, overall real economic growth had been spectacular - a 10% average in the 1960s, a 5% average in the 1970s, and a 4% average in the 1980s. Growth slowed markedly in the 1990s, averaging just 1.7%, largely because of the after effects of inefficient investment and an asset price bubble in the late 1980s that required a protracted period of time for firms to reduce excess debt, capital, and labor. Modest economic growth continued after 2000, but the economy has fallen into recession three times since 2008. A sharp downturn in business investment and global demand for Japan's exports in late 2008 pushed Japan into recession. Government stimulus spending helped the economy recover in late 2009 and 2010, but the economy contracted again in 2011 as the massive 9.0 magnitude earthquake and the ensuing tsunami in March disrupted manufacturing. The economy has largely recovered in the two years since the disaster, but reconstruction in the Tohoku region has been uneven. Prime Minister Shinzo ABE has declared the economy his government's top priority; he has overturned his predecessor's plan to permanently close nuclear power plants and is pursuing an economic revitalization agenda of fiscal stimulus, monetary easing, and structural reform. Japan joined the Trans Pacific Partnership negotiations in 2013, a pact that would open Japan's economy to increased foreign competition and create new export opportunities for Japanese businesses. Measured on a purchasing power parity (PPP) basis that adjusts for price differences, Japan in 2013 stood as the fourth-largest economy in the world after second-place China, which surpassed Japan in 2001, and third-place India, which edged out Japan in 2012. The new government will continue a longstanding debate on restructuring the economy and reining in Japan's huge government debt, which is exceeding 230% of GDP. To help raise government revenue and reduce public debt, Japan decided in 2013 to gradually increase the consumption tax to a total of 10% by the year 2015. Japan is making progress on ending deflation due to a weaker yen and higher energy costs, but reliance on exports to drive growth and an aging, shrinking population pose other major long-term challenges for the economy

Source : CIA

Company name

BIZCOM JAPAN INC.

Company summary

Country: Japan

Company name: BIZCOM JAPAN INC.

Name in local language: BIZCOM JAPAN, K.K. (株式会社ビジコムジャパン)

Office address: K2 Bldg. 7F., 5-28-1, Higashi-gotanda, Shinagawa-ku, Tokyo 141-0022

Office tel: 03-6277-3233

Office fax: 03-6277-3265

Website: www.bizcomjapan.com

Business type: Trader

Industry: Biochemical products

Established: December 24, 1996

Capital: Jp. 3,000,000 yen

Employees: 5

Corporate formation: Private

Corporation No.: 0108-01-020911 (Tokyo Legal Affairs Bureau)

MAJOR SHAREHOLDERS

Paid in capital : Jp. 3,000,000 yen

Number of authorized shares : 200 shares

Shares issued : 60 shares

Number of shareholder : 3

Name of shareholders Number of shares (%)

-----------------------------------------------------------------------------------------------------------

Mr. Masahiro Nakatani, president 20 shares (33.3)

Ms. Toshiko Nakatani 20 shares (33.3)

Mr. Hiroyasu Nakatani, director 20 shares (33.3)

-----------------------------------------------------------------------------------------------------------

Total 60 shares (100.0)

DETAILED PRODUCT CLASSFICATION & ACTIVITY

Activity Product/Service Description

-------------------------------------------------------------------------------

Trading Reagent products

Trading Raw materials for reagents

Service Contract research work for biochemical products

COMPANY MANAGEMENT

President Mr. Masahiro Nakatani

Nationality: Japan

Director Mr. Hiroyasu Nakatani

Nationality: Japan

Note: The names of director(s) and auditor(s) are phonetically spelt.

*Key Personnel*

=============

Mr. Masahiro Nakatani

President and representative director

Home address: 4-45-10, Kami-ikedai, Ota-ku, Tokyo 145-0064

FINANCIALS

Currency: (local currency - Jp. yen)

-------------------------------------------------------------------------------------

Year | Sales | Net Income

-------------------------------------------------------------------------------------

2009	40,000,000	n. a.
2010	85,000,000	n. a.
2011	140,103,000	8,048,000
2012	202,716,000	6,796,000
2013	241,600,000	1,429,000
2014	407,252,000	9,952,000

FINANCIAL DESCRIPTION

*Book Closing*

============

June 30th

*Financials*

==========

As a private limited company, no official financial statement is required to be disclosed publicly.

*Bank Details*

============

Bank Name : Mizuho Bank, Ltd.

Branch : Omori

Bank Name : Sumitomo Mitsui Banking Corp.

Branch : Hatanodai

*Credit Opinion*

=============

The subject is a Tokyo-based small-sized firm specializing in import and sales of reagent products and raw materials as well as research work.

Its business took off from 2010 term as the current directors became board members.

Sales has been rapidly growing whereas the net income goes up and down.

Customers are mostly reliable.

Negative factors are observed in particular at present though the shareholders’ equity has yet to be enhanced.

Our standard suggestion would be up to US$ 25,000 on terms of 90 days.

LOCAL BRANCHES & MANAGEMENT

Branch name: Magome office

Branch address: 1-5-10-105, Naka-magome, Ota-ku, Tokyo (registered address)

Branch tel: 03-3775-5155

Branch fax: 03-3775-8886

----------------------------------------------------------------------------------------------------

PRODUCT, TECHNOLOGY, SERVICE DESCRIPTION

*Main Products & Services*

======================

Import and sales of reagent products

Import and sales of raw materials for reagent products

Contract research work for biochemical products.

Consulting service for biotechnology.

ORGANIZATION STRUCTURE

*Address*

=========

Registered address: 1-5-10-105, Naka-magome, Ota-ku, Tokyo 143-0027

Operating head office: K2 Bldg. 7F., 5-28-1, Higashi-gotanda, Shinagawa-ku, Tokyo 141-0022

*Company History*

================

Date Development

-----------------------------------------------------------------------------------------------

December 24, 1996 Incorporated.

TRADE REFERENCES

*Suppliers*

==========

Sata Cruz Biotechnology, Inc.

BBI Solutions, Inc.

Sirion Biotech, Inc.

AbD Serotec Inc.

Access Biologicals Corp.

Bioreclamation Corp.

Cell Marque S.A.

Fitzgerald Industries, Inc.

Nova Biologicals, Inc.

*Customers*

==========

Kishida Chemical Co., Ltd. (20%)

Nichirei Bioscience Co., Ltd. (20%)

Wako Pure Chemical Industries, Ltd. (15%)

Sekisui Medical Ltd. (15%)

Mochida Pharmaceuticals Co., Ltd.

Fuji Chemical Pharma Co., Ltd.

FOREIGN EXCHANGE RATES

Currency	Unit	Indian Rupees
US Dollar	1	Rs.63.45
UK Pound	1	Rs.98.88
Euro	1	Rs.77.62

INFORMATION DETAILS

Analysis Done by :	RAS
Report Prepared by :	NIS

RATING EXPLANATIONS

RATING		STATUS	PROPOSED CREDIT LINE
>86	Aaa	Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums	Unlimited
71-85	Aa	Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums	Large
56-70	A	Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums	Fairly Large
41-55	Ba	Overall operation is considered normal. Capable to meet normal commitments.	Satisfactory
26-40	B	Capability to overcome financial difficulties seems comparatively below average.	Small
11-25	Ca	Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity	Limited with full security
<10	C	Absolute credit risk exists. Caution needed to be exercised	Credit not recommended
--	NB	New Business	--

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

Financial condition (40%) Ownership background (20%) Payment record (10%)

Credit history (10%) Market trend (10%) Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.